What is Protalus?
Protalus is dedicated to revolutionizing the footwear industry with its patented insoles and footwear designed to optimize body alignment, comfort, and support. The company's innovative approach targets common issues such as plantar fasciitis and joint pain, offering a solution that promotes natural movement and dynamic correction of misalignment. By focusing on restoring optimal body posture, Protalus caters to individuals in demanding professions like nursing, as well as athletes and those seeking enhanced daily comfort. Their commitment to customer satisfaction is further reinforced by a satisfaction guarantee, ensuring tangible relief for users.
How much funding has Protalus raised?
Protalus has raised a total of $982K across 2 funding rounds:
Debt
$350K
Debt
$632K
Debt (2020): $350K with participation from PPP
Debt (2021): $632K led by PPP
What's next for Protalus?
With the infusion of $632K in a major strategic investment, Protalus is poised for accelerated expansion. This capital injection is expected to fuel further product development, enhance manufacturing capabilities, and broaden market reach. The company's focus on addressing widespread foot and joint discomfort, coupled with its unique patented technology, positions it for substantial growth within the health and wellness footwear market. Future strategic initiatives will likely involve expanding distribution channels and potentially exploring new product lines that leverage their core alignment technology.
See full Protalus company page
